Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF
Open Access
- 19 August 2004
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 5 (7) , 553-561
- https://doi.org/10.1038/sj.gene.6364125
Abstract
One potential benefit of DNA vaccines is the capacity to elicit antibody and T-cell responses against multiple antigens at the same time by mixing plasmids expressing different proteins. A possible negative effect of such mixing is interference among plasmids regarding immunogenicity. In preparation for a clinical trial, we assessed the immunogenicity of GMP-produced plasmids encoding five Plasmodium falciparum proteins, PfCSP, PfSSP2, PfEXP1, PfLSA1, and PfLSA3, given as a mixture, or alone. The mixture induced higher levels of antibodies against whole parasites than did the individual plasmids, but was associated with a decrease in antibodies to individual P. falciparum proteins. T-cell responses were in general decreased by administration of the mixture. Immune responses to individual plasmids and mixtures were generally higher in inbred mice than in outbreds. In inbred BALB/c and C57BL/6 mice, coadministration of a plasmid expressing murine granulocyte–macrophage colony-stimulating factor (mGM-CSF), increased antibody and T-cell responses, but in outbred CD-1 mice, coadministration of mGM-CSF was associated with a decrease in antibody responses. Such variability in data from studies in different strains of mice underscores the importance of genetic background on immune response and carefully considering the goals of any preclinical studies of vaccine mixtures planned for human trials.Keywords
This publication has 25 references indexed in Scilit:
- Reduced immunogenicity of DNA vaccine plasmids in mixturesGene Therapy, 2004
- A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-γ and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factorImmunology Letters, 2002
- Multistage Multiantigen Heterologous Prime Boost Vaccine forPlasmodium knowlesiMalaria Provides Partial Protection in Rhesus MacaquesInfection and Immunity, 2001
- Protection ofAotusMonkeys byPlasmodium falciparumEBA‐175 Region II DNA Prime–Protein Boost Immunization RegimenThe Journal of Infectious Diseases, 2001
- Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA VaccineScience, 1998
- Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.The Journal of Experimental Medicine, 1996
- Quantification of antigen specific CD8+ T cells using an ELISPOT assayJournal of Immunological Methods, 1995
- Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.Proceedings of the National Academy of Sciences, 1994
- Induction of murine cytotoxic T lymphocytes againstPlasmodium falciparum sporozoite surface protein 2European Journal of Immunology, 1994
- A Plasmodium falciparum malaria vaccine candidate which contains epitopes from the circumsporozoite protein and a blood stage antigen, 5.1Molecular and Biochemical Parasitology, 1991